Toll Free: 1-888-928-9744

In-Vitro Fertilization (IVF) Market Analysis by Procedures (Intracytoplasmic Sperm Injection (ICSI), Frozen Embryo Replacement (FER), Pre-implantation Genetic Diagnosis (PGD)), By Types of Cycles (Fresh Donor, Frozen Donor, Fresh Non-donor, Frozen Non-donor), By Instruments (IVD Disposable Devices, Culture Media, Capital Equipment), And Segment Forecasts to 2022

Published: May 3, 2016 | Pages: 92 | Publisher: Grand View Research | Industry: Medical Devices | Report Format: Electronic (PDF)

Global In-Vitro Fertilization (IVF) market is expected to reach USD 27 billion by 2022, according to a new report by Grand View Research, Inc. The market is driven by the increasing incidence of infertility owing to, lifestyle changes, expansion of fertility procedures for treating male infertility such as ICSI, government initiatives to provide better reimbursement policies, and continuous efforts by the industry contributors. 

Moreover, the availability of genomic testing enabling the prevention of the transfer of genetic disease during IVF use is further expected to drive the market demand. The increase in the number of IVF treatment has led more insurance players to cover the IVF procedures. This has ultimately led to competitive pricing and has moderated the treatment costs as IVF has been a successfully practiced technology. This will most likely drive the market by introducing treatment standardization and automation. 

The behavioral shift in the society is a major factor contributing to the decreased Total Fertility Rate (TFR). These factors include an increasing number of women in the labor force, the increased age of the first birth, a shift from rural to urban societies, lower marriage rates, postponement of marriage, and greater levels of education for women. 

Obesity is another factor, which has led to an increase in infertility in the population. This is due to the fact that the fat deposited on women's abdomen prevents follicular stimulation and produces male hormones. In the case of males, the rising fat decreases testosterone levels causing a problem in sperm production. Doctors have started recommending weight loss in men prior to fertility treatments along with proper Body Mass Index (BMI) maintenance. The U.S. Endocrine Society has established the use of Letrozole to increase the testosterone levels in obese patients. 

Further key findings from the report suggest: 

Intracytoplasmic Sperm Injection (ICSI) dominated the market in 2014.ICSI was introduced in the year 1992 and boosted the fertility rates from 50% to 80%, according to the American Society for Reproductive Medicine. In April 2016, Nigeria recorded its first successful delivery from a frozen egg. Bridge Clinic has stored the eggs using the flash-freezing technique. With this birth, Nigeria has put itself on the global map as it now offers IVF through frozen eggs. The eggs were then fertilized using the ICSI technique. 

Frozen Embryo Replacement (FER) technique is expected to witness a rapid rise in demand. Conventionally, most embryos were transferred through fresh cycles. However, with technology refinement, the number of frozen embryo transfers and the success rates have increased. Moreover, the policy of freezing the embryos has also reduced the chances of ovarian hyper-stimulation. The frozen embryo transfers enable single egg transfer, thus, giving enough time for the endometrial layer to heal from the medicine stimulation effect. This ensures higher success rates. 

Culture media dominated the overall market in terms of revenue in 2014. With the increasing government funding and industrial support for employees for egg/sperm freezing, the demand for cryopreservation and the needed media for it is expected to witness growth. There has been an increase in the research activities undertaken to improve the culture media and to procure maximum boar sperms or eggs, spurring market growth. Moreover, the increasing number of egg/sperm donor banks is expected to drive the demand for sperm, egg, and embryo processing media during the forecast period. 

Europe dominated the IVF market in 2014. High quality of treatment offered at the most economical price, and the adherence to medical standards have contributed to its market leadership. In Europe, the NHS covers three IVF cycles and has also started providing coverage for gametes freezing. Moreover, the region is an attraction for international clients as countries, such as Spain, have the highest number of egg donors. The clinics also provide sex identification and other IVF treatments, which are not offered in North America. 

North America also accounted for a significant share of the market in 2014. The standardization of procedures through automation, regulatory reforms, government funding for egg/sperm storage, and industry players introducing more IVF treatments are some contributing factors for North America dominating the IVF market. 

The presence of favorable reimbursement framework (implementation of USD 50 million 5-year plans by the U.S Department of Defense for sperm/egg freezing coverage) is also expected to drive regional market growth over the next six years. The increasing number of clinics undertaking newer industrial techniques to offer better fertility success rates is also expected to boost the regional market demand. 

The demand for IVF treatment is expected to boom in APAC owing to fertility tourism, increasing foreign industries trying to penetrate the economically developing countries and the changing regulatory landscape. 

The Asia Pacific Initiative on Reproduction (ASPIRE), the task force of clinicians and scientists is involved in the monitoring and management of fertility and Assisted Reproductive Technology (ART). Such initiatives promote awareness levels thereby, driving growth. 

Industry contributors are introducing newer automation to shift the IVF treatment from invasive to a minimally invasive or non-invasive procedure. The industry players are also trying technologies, which can enable older women to have enhanced fertility rates. For instance, in August 2015, OvaScience announced the results of its first published analysis comparing AUGMENT fertility treatment with a standard IVF. The results showed a significantly higher rate of selection and transfer of embryos as compared to the standard treatment. 

Some key players in this market includeEMD Serono Inc., Boston IVF, OvaScience, Thermo Fisher Scientific Inc., Vitrolife AB, Irvine Scientific, CooperSurgical, Inc., Cook Medical Inc., Genea Biomedx and Progyny Inc. 
 Table of Contents
Chapter 1. Methodology and Scope 1.1. Research methodology 1.2. Research scope & assumption 1.3. List of data sources Chapter 2. Executive Summary 2.1. In-Vitro Fertilization (IVF) Market - Industry Summary and Key Buying Criteria, 2012 - 2022 Chapter 3. In-Vitro Fertilization (IVF)Industry Outlook 3.1. In-Vitro Fertilization (IVF) Market Segmentation 3.2. In-Vitro Fertilization (IVF) Market Size and Growth Prospects 3.3. In-Vitro Fertilization (IVF) Market Dynamics 3.3.1. Market Driver Analysis 3.3.2. Market Restraint Analysis 3.4. Key Opportunities Prioritized 3.5. Industry analysis - Porter's 3.6. In-Vitro Fertilization (IVF) Market PESTEL Analysis, 2014 3.7. Competitive landscape Chapter 4. In-Vitro Fertilization (IVF)Procedures Outlook 4.1. In-Vitro Fertilization (IVF)Market Share by procedures, 2014 & 2022 4.2. Intracytoplasmic Sperm Injection(ICSI) Market Estimates and Forecasts, 2012 - 2022 (USD Million) 4.3. Frozen Embryo Replacement (FER) Market Estimates and Forecasts, 2012 - 2022 (USD Million) 4.4. Pre-implantation Genetic Diagnosis (PGD) Market Estimates and Forecasts, 2012 - 2022 (USD Million) 4.5. Others Market Estimates and Forecasts, 2012 - 2022 (USD Million) Chapter 5. In-Vitro Fertilization (IVF) Type of Cycles Outlook 5.1. In-Vitro Fertilization (IVF) Market Share by type of cycles, 2014 & 2022 5.2. Fresh Donor Market Estimates and Forecasts, 2012 - 2022 (USD Million) 5.3. Fresh Non-donor Market Estimates And Forecasts, 2012 - 2022 (USD Million) 5.4. Frozen Donor Market Estimates and Forecasts, 2012 - 2022 (USD Million) 5.5. Frozen Non-donor Market Estimates And Forecasts, 2012 - 2022 (USD Million) Chapter 6. In-Vitro Fertilization (IVF) Instruments Outlook 6.1. In-Vitro Fertilization (IVF) Market Share by instruments, 2014 & 2022 6.2. Culture media Market Estimates and Forecasts, 2012 - 2022 (USD Million) 6.3. Capital equipment Market Estimates and Forecasts, 2012 - 2022 (USD Million) 6.4. IVF disposable devices Market Estimates and Forecasts, 2012 - 2022 (USD Million) Chapter 7. In-Vitro Fertilization (IVF)Regional Outlook 7.1. North America 7.1.1. North America In-Vitro Fertilization (IVF) Market Estimates And Forecasts, By Procedures, 2012 - 2022 (USD Million) 7.1.1.1. U.S. Market Estimates and Forecasts, 2012 - 2022 (USD Million) 7.1.1.2. Canada Market Estimates and Forecasts, 2012 - 2022 (USD Million) 7.1.2. North America In-Vitro Fertilization (IVF) Market Estimates And Forecasts, By Type of Cycles, 2012 - 2022 (USD Million) 7.1.2.1. U.S Market Estimates and Forecasts, 2012 - 2022 (USD Million) 7.1.2.2. Canada Market Estimates and Forecasts, 2012 - 2022 (USD Million) 7.1.3. North America In-Vitro Fertilization (IVF) Market Estimates and Forecasts, By Instruments, 2012 - 2022 (USD Million) 7.1.3.1. U.S. Market Estimates and Forecasts, 2012 - 2022 (USD Million) 7.1.3.2. Canada Market Estimates and Forecasts, 2012 - 2022 (USD Million) 7.2. Europe 7.2.1. Europe In-Vitro Fertilization (IVF) Market Estimates and Forecasts, By Procedures, 2012 - 2022 (USD Million) 7.2.1.1. UK Market Estimates and Forecasts, 2012 - 2022 (USD Million) 7.2.1.2. France Market Estimates and Forecasts, 2012 - 2022 (USD Million) 7.2.1.3. Germany Market Estimates and Forecasts, 2012 - 2022 (USD Million) 7.2.2. Europe In-Vitro Fertilization (IVF) Market Estimates and Forecasts, By Type of Cycles, 2012 - 2022 (USD Million) 7.2.2.1. UK Market Estimates and Forecasts, 2012 - 2022 (USD Million) 7.2.2.2. France Market Estimates and Forecasts, 2012 - 2022 (USD Million) 7.2.2.3. Germany Market Estimates and Forecasts, 2012 - 2022 (USD Million) 7.2.3. Europe In-Vitro Fertilization (IVF) Market Estimates and Forecasts, By Instruments, 2012 - 2022 (USD Million) 7.2.3.1. UK Market Estimates and Forecasts, 2012 - 2022 (USD Million) 7.2.3.2. France Market Estimates and Forecasts, 2012 - 2022 (USD Million) 7.2.3.3. Germany Market Estimates and Forecasts, 2012 - 2022 (USD Million) 7.3. Asia Pacific 7.3.1. Asia Pacific In-Vitro Fertilization (IVF) Market Estimates and Forecasts, By Procedures, 2012 - 2022 (USD Million) 7.3.1.1. India Market Estimates and Forecasts, 2012 - 2022 (USD Million) 7.3.1.2. China Market Estimates and Forecasts, 2012 - 2022 (USD Million) 7.3.1.3. Japan Market Estimates and Forecasts, 2012 - 2022 (USD Million) 7.3.2. Asia Pacific In-Vitro Fertilization (IVF) Market Estimates and Forecasts, By Type of Cycles, 2012 - 2022 (USD Million) 7.3.2.1. India Market Estimates and Forecasts, 2012 - 2022 (USD Million) 7.3.2.2. China Market Estimates and Forecasts, 2012 - 2022 (USD Million) 7.3.2.3. Japan Market Estimates and Forecasts, 2012 - 2022 (USD Million) 7.3.3. Asia Pacific In-Vitro Fertilization (IVF) Market Estimates and Forecasts, By Instruments, 2012 - 2022 (USD Million) 7.3.3.1. India Market Estimates and Forecasts, 2012 - 2022 (USD Million) 7.3.3.2. China Market Estimates and Forecasts, 2012 - 2022 (USD Million) 7.3.3.3. Japan Market Estimates and Forecasts, 2012 - 2022 (USD Million) 7.4. Latin America 7.4.1. Latin America In-Vitro Fertilization (IVF) Market Estimates and Forecasts, By Procedures, 2012 - 2022 (USD Million) 7.4.1.1. Mexico market estimates and forecasts, 2012 - 2022 (USD Million) 7.4.1.2. Brazil market estimates and forecasts, 2012 - 2022 (USD Million) 7.4.2. Latin America In-Vitro Fertilization (IVF) Market Estimates and Forecasts, By Type of Cycles, 2012 - 2022 (USD Million) 7.4.2.1. Mexico market estimates and forecasts, 2012 - 2022 (USD Million) 7.4.2.2. Brazil market estimates and forecasts, 2012 - 2022 (USD Million) 7.4.3. Latin America In-Vitro Fertilization (IVF) Market Estimates and Forecasts, By Instruments, 2012 - 2022 (USD Million) 7.4.3.1. Mexico market estimates and forecasts, 2012 - 2022 (USD Million) 7.4.3.2. Brazil market estimates and forecasts, 2012 - 2022 (USD Million) 7.5. MEA 7.5.1. MEA In-Vitro Fertilization (IVF) Market Estimates and Forecasts, By Procedures, 2012 - 2022 (USD Million) 7.5.1.1. South Africa Market Estimates and Forecasts, 2012 - 2022 (USD Million) 7.5.2. MEA In-Vitro Fertilization (IVF) Market Estimates and Forecasts, By Type of Cycles, 2012 - 2022 (USD Million) 7.5.2.1. South Africa Market Estimates and Forecasts, 2012 - 2022 (USD Million) 7.5.3. MEA In-Vitro Fertilization (IVF) Market Estimates and Forecasts, By Instruments, 2012 - 2022 (USD Million) 7.5.3.1. South Africa Market Estimates and Forecasts, 2012 - 2022 (USD Million) Chapter 8. Competitive Landscape 9.1 OvaScience 9.1.1 Company Overview 9.1.2 Financial Performance 9.1.3 Product Benchmarking 9.1.4 Strategic Initiatives 9.2 Vitrolife AB 9.2.1 Company Overview 9.2.2 Financial Performance 9.2.3 Product Benchmarking 9.2.4 Strategic initiatives 9.3 EMD Serono, Inc. 9.3.1 Company Overview 9.3.2 Financial Performance 9.3.3 Products Benchmarking 9.3.4 Strategic initiatives 9.4 Irvine Scientific 9.4.1 Company Overview 9.4.2 Financial Performance 9.4.3 Product Benchmarking 9.4.4 Strategic initiatives 9.5 CooperSurgical, Inc. 9.5.1 Company Overview 9.5.2 Financial Performance 9.5.3 Products Benchmarking 9.5.4 Strategic initiatives 9.6 Cook Medical, Inc. 9.6.1 Company Overview 9.6.2 Financial Performance 9.6.3 Product Benchmarking 9.6.4 Strategic initiatives 9.7 Thermo Fisher Scientific, Inc. 9.7.1 Company Overview 9.7.2 Financial Performance 9.7.3 Products Benchmarking 9.7.4 Strategic initiatives 9.8 Genea Biomedx 9.8.1 Company Overview 9.8.2 Financial Performance 9.8.3 Product Benchmarking 9.8.4 Strategic Initiatives 9.9 Progyny,Inc. 9.9.1 Company Overview 9.9.2 Financial Performance 9.9.3 Product Benchmarking 9.9.4 Strategic Initiatives 9.10 Boston IVF 9.10.1 Company Overview 9.10.2 Financial Performance 9.10.3 Product Benchmarking 9.10.4 Strategic Initiatives
List of Tables
1. In-Vitro Fertilization (IVF) Market - Industry Summary & Key Buying Criteria, 2012 - 2022 2. In-Vitro Fertilization (IVF) Market, by Procedures, 2012 to 2022 (USD million) 3. In-Vitro Fertilization (IVF) Market, by Type of Cycles, 2012 to 2022 (USD million) 4. In-Vitro Fertilization (IVF) Market, by Instruments, 2012 to 2022 (USD million) 5. In-Vitro Fertilization (IVF) Market, by Region, 2012 to 2022 (USD million) 6. In-Vitro Fertilization (IVF) Market - Key Market Drivers Analysis 7. In-Vitro Fertilization (IVF) Market - Key Market Restraints Analysis 8. North America Market, by Procedures, 2012 to 2022 (USD million) 9. North America Market, by Type of Cycles, 2012 to 2022 (USD million) 10. North America Market, by Instruments, 2012 to 2022 (USD million) 11. U.S. Market, by Procedures, 2012 to 2022 (USD million) 12. U.S. Market, by Type of Cycles, 2012 to 2022 (USD million) 13. U.S. Market, by Instruments, 2012 to 2022 (USD million) 14. Canada Market, by Procedures, 2012 to 2022 (USD million) 15. Canada Market, by Type of Cycles, 2012 to 2022 (USD million) 16. Canada Market, by Instruments, 2012 to 2022 (USD million) 17. Europe Market, by Procedures, 2012 to 2022 (USD million) 18. Europe Market, by Type of Cycles, 2012 to 2022 (USD million) 19. Europe Market, by Instruments, 2012 to 2022 (USD million) 20. UK Market, by Procedures, 2012 to 2022 (USD million) 21. UK Market, by Type of Cycles, 2012 to 2022 (USD million) 22. UK Market, by Instruments, 2012 to 2022 (USD million) 23. France Market, by Procedures, 2012 to 2022 (USD million) 24. France Market, by Type of Cycles, 2012 to 2022 (USD million) 25. France Market, by Instruments, 2012 to 2022 (USD million) 26. Germany Market, by Procedures, 2012 to 2022 (USD million) 27. Germany Market, by Type of Cycles, 2012 to 2022 (USD million) 28. Germany Market, by Instruments, 2012 to 2022 (USD million) 29. Asia Pacific Market, by Procedures, 2012 to 2022 (USD million) 30. Asia Pacific Market, by Type of Cycles, 2012 to 2022 (USD million) 31. Asia Pacific Market, by Instruments, 2012 to 2022 (USD million) 32. Japan Market, by Procedures, 2012 to 2022 (USD million) 33. Japan Market, by Type of Cycles, 2012 to 2022 (USD million) 34. Japan Market, by Instruments, 2012 to 2022 (USD million) 35. China Market, by Procedures, 2012 to 2022 (USD million) 36. China Market, by Type of Cycles, 2012 to 2022 (USD million) 37. China Market, by Instruments, 2012 to 2022 (USD million) 38. India Market, by Procedures, 2012 to 2022 (USD million) 39. India Market, by Type of Cycles, 2012 to 2022 (USD million) 40. India Market, by Instruments, 2012 to 2022 (USD million) 41. Latin America Market, by Procedures, 2012 to 2022 (USD million) 42. Latin America Market, by Type of Cycles, 2012 to 2022 (USD million) 43. Latin America Market, by Instruments, 2012 to 2022 (USD million) 44. Mexico Market, by Procedures, 2012 to 2022 (USD million) 45. Mexico Market, by Type of Cycles, 2012 to 2022 (USD million) 46. Mexico Market, by Instruments, 2012 to 2022 (USD million) 47. Brazil Market, by Procedures, 2012 to 2022 (USD million) 48. Brazil Market, by Type of Cycles, 2012 to 2022 (USD million) 49. Brazil Market, by Instruments, 2012 to 2022 (USD million) 50. MEA Market, by Procedures, 2012 to 2022 (USD million) 51. MEA Market, by Type of Cycles, 2012 to 2022 (USD million) 52. MEA Market, by Instruments, 2012 to 2022 (USD million) 53. South Africa Market, by Procedures, 2012 to 2022 (USD million) 54. South Africa Market, by Type of Cycles, 2012 to 2022 (USD million) 55. South Africa Market, by Instruments, 2012 to 2022 (USD million)


List of Figures
1. In-Vitro Fertilization (IVF) Market Segmentation 2. Global In-Vitro Fertilization (IVF) Market Revenue, 2012 - 2022 3. In-Vitro Fertilization (IVF) Market Dynamics 4. Key Opportunities Prioritized 5. In-Vitro Fertilization (IVF) Market Analysis - Porter's 6. In-Vitro Fertilization (IVF) Market Analysis - PESTEL Analysis 7. Global In-Vitro Fertilization (IVF)Market, By Procedures, 2012 to 2022 (USD million) 8. Intracytoplasmic Sperm Injection(ICSI) Market, 2012 to 2022 (USD million) 9. Frozen Embryo Replacement (FER) Market, 2012 to 2022 (USD million) 10. Pre-implantation Genetic Diagnosis (PGD)Market, 2012 to 2022 (USD million) 11. Global In-Vitro Fertilization (IVF) Market, By Type of Cycles, 2012 to 2022 (USD million) 12. Fresh Donor Market 2012 to 2022 (USD million) 13. Fresh Non-donor Market 2012 to 2022 (USD million) 14. Frozen Donor Market 2012 to 2022 (USD million) 15. Frozen Non-donor Market 2012 to 2022 (USD million) 16. Global In-Vitro Fertilization (IVF) Market, By Instruments, 2012 to 2022 (USD million) 17. Culture Media Market 2012 to 2022 (USD million) 18. Capital Equipment Market 2012 to 2022 (USD million) 19. IVF Disposable Devices Market 2012 to 2022 (USD million) 20. Global In-Vitro Fertilization (IVF)Market, By Region 2012 to 2022 (USD million) 21. North America Market, by Procedures, 2012 to 2022 (USD million) 22. North America Market, by Type of Cycles, 2012 to 2022 (USD million) 23. North America Market, by Instruments, 2012 to 2022 (USD million) 24. U.S. Market, by Procedures, 2012 to 2022 (USD million) 25. U.S. Market, by Type of Cycles, 2012 to 2022 (USD million) 26. U.S. Market, by Instruments, 2012 to 2022 (USD million) 27. Canada Market, by Procedures, 2012 to 2022 (USD million) 28. Canada Market, by Type of Cycles, 2012 to 2022 (USD million) 29. Canada Market, by Instruments, 2012 to 2022 (USD million) 30. Europe Market, by Procedures, 2012 to 2022 (USD million) 31. Europe Market, by Type of Cycles, 2012 to 2022 (USD million) 32. Europe Market, by Instruments, 2012 to 2022 (USD million) 33. UK Market, by Procedures, 2012 to 2022 (USD million) 34. UK Market, by Type of Cycles, 2012 to 2022 (USD million) 35. UK Market, by Instruments, 2012 to 2022 (USD million) 36. France Market, by Procedures, 2012 to 2022 (USD million) 37. France Market, by Type of Cycles, 2012 to 2022 (USD million) 38. France Market, by Instruments, 2012 to 2022 (USD million) 39. Germany Market, by Procedures, 2012 to 2022 (USD million) 40. Germany Market, by Type of Cycles, 2012 to 2022 (USD million) 41. Germany Market, by Instruments, 2012 to 2022 (USD million) 42. Asia Pacific Market, by Procedures, 2012 to 2022 (USD million) 43. Asia Pacific Market, by Type of Cycles, 2012 to 2022 (USD million) 44. Asia Pacific Market, by Instruments, 2012 to 2022 (USD million) 45. Japan Market, by Procedures, 2012 to 2022 (USD million) 46. Japan Market, by Type of Cycles, 2012 to 2022 (USD million) 47. Japan Market, by Instruments, 2012 to 2022 (USD million) 48. China Market, by Procedures, 2012 to 2022 (USD million) 49. China Market, by Type of Cycles, 2012 to 2022 (USD million) 50. China Market, by Instruments, 2012 to 2022 (USD million) 51. India Market, by Procedures, 2012 to 2022 (USD million) 52. India Market, by Type of Cycles, 2012 to 2022 (USD million) 53. India Market, by Instruments, 2012 to 2022 (USD million) 54. Latin America Market, by Procedures, 2012 to 2022 (USD million) 55. Latin America Market, by Type of Cycles, 2012 to 2022 (USD million) 56. Latin America Market, by Instruments, 2012 to 2022 (USD million) 57. Mexico Market, by Procedures, 2012 to 2022 (USD million) 58. Mexico Market, by Type of Cycles, 2012 to 2022 (USD million) 59. Mexico Market, by Instruments, 2012 to 2022 (USD million) 60. Brazil Market, by Procedures, 2012 to 2022 (USD million) 61. Brazil Market, by Type of Cycles, 2012 to 2022 (USD million) 62. Brazil Market, by Instruments, 2012 to 2022 (USD million) 63. MEA Market, by Procedures, 2012 to 2022 (USD million) 64. MEA Market, by Type of Cycles, 2012 to 2022 (USD million) 65. MEA Market, by Instruments, 2012 to 2022 (USD million) 66. South Africa Market, by Procedures, 2012 to 2022 (USD million) 67. South Africa Market, by Type of Cycles, 2012 to 2022 (USD million) 68. South Africa Market, by Instruments, 2012 to 2022 (USD million)

To request a free sample copy of this report, please complete the form below.

This website is secure and your personal details are safe. Privacy policy

Global automotive collision repair market is expected to be valued at USD 196.97 billion by 2020, as per a new research report by Radiant Insights, Inc. The industry is expected to witness significant growth owing to increasing number of on-road vehi

Read More...

Global geotextile market size is likely to be valued at USD 8.24 billion by 2020; as per a new research report by Radiant Insights, Inc. Increasing use in soil reinforcement activity coupled with growing application scope in road & railway developmen

Read More...

Global aerospace plastics market size is likely to be valued at USD 13.48 billion by 2020; as per a new research report by Radiant Insights, Inc. Growing application scope of lightweight materials in aerospace industry is likely to drive market growt

Read More...

Global automotive relay market is anticipated to reach USD 12 billion by 2020, as per a new research report by Radiant Insights, Inc. Rising need for high-frequency signals in automotive industry is expected to drive demand. These relays enhance driv

Read More...

Global air traffic control equipment market is projected to reach USD 4.2 billion by 2020, as per a new research report by Radiant Insights, Inc. Mounting price sensitivity among customers with introduction of low fare airlines is expected to drive t

Read More...
Choose License Type
Single User - US $4950
Multi User - US $7950
Why Choose Us

24/5 Research support

Get your queries resolved from an industry expert. Request for a free product review before report purchase.

Phone: 1-415-349-0054

Toll Free: 1-888-928-9744

Email: [email protected]

Custom research service

Speak to the report author to design an exclusive study to serve your research needs.

Quality assurance

A testimonial for service excellence represented in the form of BBB "A" Accreditation.

Information security

Your personal and confidential information is safe and secure.

verify